2018-12-11

Added 2026-06-23 · Updated 2026-07-08

FS20/2: Patient Capital and Authorised Funds

The Financial Conduct Authority issued this feedback statement to provide final guidance on patient capital and authorised funds following the consultation in DP18/10. The document outlines the regulator's responses to stakeholder comments and details the specific changes to rules and expectations regarding long-term investment strategies. It establishes the definitive framework for firms managing authorised funds to align with the FCA's objectives for fostering patient capital in the UK market.

United Kingdom

Financial Conduct Authority

Follow FCA

Show thumbnailShow full textSourceAdd to collection

Show full text

Open discussion: DP18/10

12/12/2018

Discussion closed

28/02/2019

Feedback Statement (FS20/2)

28/02/2020

28/02/2020